BÜCHER VERSANDKOSTENFREI INNERHALB DEUTSCHLANDS
eBook
New Rapid-acting Antidepressants
Springer International Publishing
ISBN 978-3-030-79790-4
Standardpreis
Bibliografische Daten
eBook. PDF. Weiches DRM (Wasserzeichen)
2021
VII, 149 p. 14 illus., 9 illus. in color..
In englischer Sprache
Umfang: 149 S.
Verlag: Springer International Publishing
ISBN: 978-3-030-79790-4
Weiterführende bibliografische Daten
Das Werk ist Teil der Reihe: Contemporary Clinical Neuroscience
Produktbeschreibung
This book discusses new candidates for rapid-acting antidepressants, such as (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3 antagonists and AMPA receptor agonists. There are serious limitations to currently available antidepressants, such as delayed onset and low rates of efficacy. The discovery that a single dose of ketamine, an NMDAR antagonist, can produce rapid antidepressant effects that are sustained has led to new research in this area. In this volume, a variety of novel pharmaceutical treatments are examined. This volume would be useful to both researchers and clinicians who work in the field of pharmacology, specifically CNS drug treatments.
Discusses new candidate for rapid-acting antidepressants
Provides information for those who work in the field of CNS drugs
Ideal for pharmacologists, psychiatrists, and those who want to learnabout CNS drugs at the graduate level
Autorinnen und Autoren
Produktsicherheit
Hersteller
Springer Nature Customer Service Center GmbH
ProductSafety@springernature.com
Rezensionen
